Challenges in the clinical development of non-D2 compounds for schizophrenia
Author:
Affiliation:
1. Sunovion Pharmaceuticals Inc, Marlborough, MA, USA
Funder
Sunovion Pharmaceuticals Inc.
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2147342
Reference33 articles.
1. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
2. Neuroimaging Biomarkers in Schizophrenia
3. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors
4. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
5. New approaches to antipsychotic medication adherence – safety, tolerability and acceptability
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression;Psychiatry Research;2024-10
2. A clinical trial inclusion criteria to enrich for patients presenting with canonical symptom structure in bipolar depression;Contemporary Clinical Trials;2024-10
3. Pharmacologic Treatment of Schizophrenia Beyond Dopamine Receptor Blockade—Has Its Time Come Yet?;JAMA Psychiatry;2023-12-13
4. Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study;Frontiers in Psychiatry;2023-12-04
5. Finding new and better treatments for psychiatric disorders;Neuropsychopharmacology;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3